Allentown Fibromyalgia Test & Genetic Screening Microbiome Assessment Update

Allentown,United States - June 8, 2022 /PressCable/ —

The new test takes into consideration the ever-increasing number of fibromyalgia patients in America. To date, there are around 4 million US adults, or about 2% of the adult population, who suffer from the condition. Experts expect this number to rise in the next few years, although they are still determining the reasons for this trend.

More details can be found at https://avriogenetics.com/fibro-kit-lite

The condition is considered a lifelong illness that can be effectively managed through proper medication and lifestyle changes. Studies have shown that early detection can lead to better management plans; still, many patients are misdiagnosed because of inadequate fibromyalgia screening facilities and tests. Aware of this, Avrio Genetics is proud to announce its new FibroKit Lite.

Its FibroKit Lite powered by Pronacera is a state-of-the-art tool for managing fibromyalgia symptoms. The genetic screening test assesses two parameters that are linked to the onset and advancement of the disease’s symptoms. These are mitochondria health and intestinal microbiota.

The company explains that mitochondria are key to controlling oxidative stress and inflammation. When it doesn’t function properly, it can lead to central and peripheral sensitization typically seen in fibromyalgia.

On the other hand, intestinal microbiota has been studied to be closely linked to the condition. Studies have shown that changes to the intestinal barrier of the microbiota can trigger immunological consequences such as autoimmune disorders.

The new test determines the health of these two factors. If either is considered to be compromised, patients are more vulnerable to developing the disease.

FibroKit Lite is not limited to detection. The screening test can also be used for prevention, as doctors will be able to anticipate the negative progression of the patient’s symptoms and customize a treatment plan for them based on the results of the test.

FibroKit Lite is recommended for those who suffer from chronic generalized pain, present gastrointestinal problems without clinical cause, or who have a history of the condition in their family.

Avrio Genetics is the leading genetics screening center in Allentown, PA. It specializes in packages for couples looking to conceive.

Interested parties can find more information by visiting https://avriogenetics.com

Contact Info:
Name: Brandon Hensinger
Email: Send Email
Organization: Avrio Genetics LLC
Address: 3467 Trexler Blvd, Allentown, PA 18104, United States
Phone: +1-919-345-1087
Website: http://www.AvrioGenetics.com

Source: PressCable

Release ID: 89076359

If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 8 hours.